Mallinckrodt plc 4
4 · Mallinckrodt plc · Filed May 14, 2015
Insider Transaction Report
Form 4
BAILEY DON M
Director
Transactions
- Sale
Ordinary Shares
2015-05-13$123.18/sh−1,400$172,452→ 139,607 total - Exercise/Conversion
Ordinary Shares
2015-05-13$26.95/sh+51,417$1,385,688→ 191,024 total - Sale
Ordinary Shares
2015-05-13$122.43/sh−50,017$6,123,581→ 141,007 total - Exercise/Conversion
Stock Options (Right to Buy)
2015-05-13−51,417→ 0 totalExercise: $26.95Exp: 2022-02-15→ Ordinary Shares (51,417 underlying)
Footnotes (4)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on November 26, 2014.
- [F2]The price represents a weighted average. The shares were sold at prices ranging from $122.02 to $123.00, inclusive. Mr. Bailey will provide, upon request of the SEC staff, Mallinckrodt plc, or a shareholder of Mallinckrodt plc complete information regarding the number of shares sold at each price within the ranges set forth in footnotes (2) - (3) to this Form 4.
- [F3]The price represents a weighted average. The shares were sold at prices ranging from $123.12 to $123.50, inclusive.
- [F4]Represents options to purchase shares of Questcor Pharmaceuticals, Inc. that were converted into options to purchase ordinary shares of Mallinckrodt plc pursuant to the Agreement and Plan of Merger, dated as of April 5, 2014, by and among Mallinckrodt plc ("Mallinckrodt"), Questcor Pharmaceuticals, Inc. ("Questcor") and Quincy Merger Sub, Inc. All unvested options were accelerated on August 14, 2014 in connection with the acquisition of Questcor by Mallinckrodt.